As part of our ongoing commitment to improve and ensure transparency and fairness to our clients, we are pleased to announce that as of December 8,2008, Finotec will be switching to a new pricing method
Rodian Rahnayev
As part of our ongoing commitment to improve and ensure transparency and fairness to our clients, we are pleased to announce that as of December 8,2008, Finotec will be switching to a new pricing method. From now on, we will be providing you with real market prices. This means that the price displayed will be the market price to which will be added a fixed commission, guaranteeing total transparency.Finotec is regulated by both the FSA (Financial Services Authority, U.K.) and the SEC (U.S. Securities
and Exchange Commission). Under these strict regulations, Finotec is required to file detailed quarterly reports with the SEC and is subject to daily controls by the FSA. In addition, client funds are insured by the FSA up to an amount set by its discretion. Please note that Finotec will implement further measures in the near future in order to provide you with more secure and fairer trades and improve your satisfaction.For more information, please contact your Finotec Account Manager. Best regards, The Finotec Dealing Room
Trading in Foreign Exchange, CFDs, Options, Futures and Commodities and engaging in Spread Betting on financial products carries a high degree of risk to your capital and it is possible to lose more than your initial investment. You should only speculate with money that you can afford to lose. These products may not be suitable for all investors, therefore please ensure that you fully understand the risks involved and seek independent advice if necessary. Finotec Trading UK Ltd is authorized and regulated by the Financial Services Authority.
FSA Register Number [470392]Finotec Trading UK, Bridge House, London Bridge, London, SE1 9QR, United Kingdom Copyright © 1998- 2008 Finotec Group Inc.SEC-OTCBB # All rights reserved.
Finotec Analysis Team
08 December 2008
The market review and analysis content on this site, including news, quotes, data and other information, is provided for your personal information only, and is not intended as a recommendation for trading purposes. Content on this site does not provide any form of advice (investment, tax, legal) amounting to investment advice, or make any recommendations regarding particular financial instruments, investments or products. Finotec does not provide investment advice or recommendations to buy or sell securities.